PathologybioRxivPreprint
Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome
John M. Starbuck, Sergi Llambrich, Ruben González…·Neus Martínez-Abadías
This study shows EGCG treatment improves facial dysmorphology in DS mouse models and humans but warns against non-prescribed use due to variable outcomes.